Literature DB >> 32470891

Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.

Adebola Adedimeji1, Rogers Ajeh2, Anastase Dzudie2, Ernestine Kendowo2, Norbert Fuhngwa2, Denis Nsame3, Andre Gaetan Simo-Wambo3, Enow Orock4, Tiffany M Hebert1, Amanda J Pierz1, Daniel Murokora5, Kathryn Anastos1, Philip E Castle6.   

Abstract

BACKGROUND: There are limited data on cervical HPV prevalence in Cameroon and none from its Anglophone region. We investigated cervical HPV prevalence in HIV-uninfected (HIV[-]) and HIV-infected (WLWH) women living in the region.
METHODS: A convenience sample of consecutively recruited HIV[-] women (n = 295) and women living with HIV (WLWH) (n = 560) attending the Limbé Regional Hospital were enrolled into a cervical screening study. Women underwent screening that included HPV testing of self-collected and provider-collected specimens. We calculated the HPV prevalence by HIV status, overall and stratified by age, and among WLWH, stratified by CD4 counts. We compared the concordance for the detection of HPV between self- and provider-collected specimens.
RESULTS: Crude HPV prevalence was 21.69 % (95 % confidence interval [95 %CI] = 17.21-26.48 %) for HIV[-] women and 46.43 % (95 %CI = 42.24-50.66 %) for WLWH (p < 0.001). Among WLWH, older age (ptrend = 0.01) and higher CD4 counts (ptrend = 0.007) were associated with lower HPV prevalence. There was a good-to-excellent agreement for HPV detection between specimens, and self-collected were more likely than provider-collected specimens to test HPV positive, for all women and stratified by HIV status.
CONCLUSIONS: HIV-related immunosuppression was a risk factor for HPV prevalence in this population. HPV testing of self-collected specimens appeared to be less specific than HPV testing of provider-collected specimens.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Screening; Self-collection

Mesh:

Substances:

Year:  2020        PMID: 32470891      PMCID: PMC7809577          DOI: 10.1016/j.jcv.2020.104445

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  32 in total

1.  Risk factors associated with human papillomavirus prevalence and cervical neoplasia among Cameroonian women.

Authors:  Rosa Catarino; Pierre Vassilakos; Pierre-Marie Tebeu; Sonja Schäfer; Adamo Bongoe; Patrick Petignat
Journal:  Cancer Epidemiol       Date:  2015-11-25       Impact factor: 2.984

2.  Twelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIV.

Authors:  Gad Murenzi; Faustin Kanyabwisha; Anthere Murangwa; Gallican Kubwimana; Leon Mutesa; Robert D Burk; Kathryn Anastos; Philip E Castle
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

3.  Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Authors:  Alison G Abraham; Gypsyamber D'Souza; Yuezhou Jing; Stephen J Gange; Timothy R Sterling; Michael J Silverberg; Michael S Saag; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Richard D Moore; Marina B Klein; Mari M Kitahata; Gregory D Kirk; Robert S Hogg; Nancy A Hessol; James J Goedert; M John Gill; Kelly A Gebo; Joseph J Eron; Eric A Engels; Robert Dubrow; Heidi M Crane; John T Brooks; Ronald J Bosch; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

4.  International correlation between human papillomavirus prevalence and cervical cancer incidence.

Authors:  Delphine Maucort-Boulch; Silvia Franceschi; Martyn Plummer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

Review 5.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.

Authors:  Silvia de Sanjosé; Mireia Diaz; Xavier Castellsagué; Gary Clifford; Laia Bruni; Nubia Muñoz; F Xavier Bosch
Journal:  Lancet Infect Dis       Date:  2007-07       Impact factor: 25.071

6.  Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting.

Authors:  Pierre-Marie Tebeu; Joël Fokom-Domgue; Victoria Crofts; Emmanuel Flahaut; Rosa Catarino; Sarah Untiet; Pierre Vassilakos; Patrick Petignat
Journal:  Int J Cancer       Date:  2014-10-18       Impact factor: 7.396

7.  Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.

Authors:  Michel Segondy; Helen Kelly; Mahlape P Magooa; Florencia Djigma; Jean Ngou; Clare Gilham; Tanvier Omar; Olga Goumbri-Lompo; Pamela Michelow; Sylviane Doutre; Omar Clavero; Admire Chikandiwa; Bernard Sawadogo; Marie-Noelle Didelot; Valérie Costes; Nicolas Méda; Sinead Delany-Moretlwe; Philippe Mayaud
Journal:  Br J Cancer       Date:  2016-07-19       Impact factor: 7.640

8.  Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach.

Authors:  Margot Kunckler; Fanny Schumacher; Bruno Kenfack; Rosa Catarino; Manuela Viviano; Eveline Tincho; Pierre-Marie Tebeu; Liliane Temogne; Pierre Vassilakos; Patrick Petignat
Journal:  Cancer Med       Date:  2017-06-04       Impact factor: 4.452

9.  Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.

Authors:  Johnson Katanga; Susanne K Kjaer; Rachel Manongi; Chun Sen Wu; Thomas Iftner; Marianne Waldstrom; Andrea B Pembe; Julius Mwaiselage; Vibeke Rasch
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

10.  HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.

Authors:  Eshetu Lemma Haile; Simoens Cindy; Benoy Ina; Gurja Belay; Van Geertruyden Jean-Pierre; Ransom Sharon; Lebelo Ramokone Lisbeth; Bogers Johannes Paul
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

View more
  1 in total

1.  A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon.

Authors:  Philip E Castle; Rogers Ajeh; Anastase Dzudie; Ernestine Kendowo; Norbert Fuhngwa; Andre Gaetan Simo-Wambo; Denis Nsame; Enow Orock; Tiffany M Hebert; Amanda J Pierz; Daniel Murokora; Kathryn Anastos; Adebola Adedimeji
Journal:  Infect Agent Cancer       Date:  2020-07-11       Impact factor: 2.965

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.